Treating claudication in five words.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Exercise for intermittent claudication.The Cochrane database of systematic reviews · 2017
   Pooled it
2. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.Journal of vascular surgery · 2008
   Trial
3. Pharmacological approaches to the treatment of intermittent claudication.Drugs & aging
   Trial
4. Serum proteomics of active tuberculosis patients and contacts reveals unique processes activated during Mycobacterium tuberculosis infection.Scientific reports · 2020
   Article
5. Implementation of a supervised exercise therapy programme.Annals of the Royal College of Surgeons of England · 2019
   Article
6. Metabolic inertia in contracting skeletal muscle: a novel approach for pharmacological intervention in peripheral vascular disease.British journal of clinical pharmacology · 2004
   Review
7. Smoking--do vascular surgeons practise what they preach?Annals of the Royal College of Surgeons of England · 2000
   Article
8. Walking to health.Sports medicine (Auckland, N.Z.) · 1997
   Review
9. Analgesia in the elderly. Practical treatment recommendations.Drugs & aging · 1996
   Review
10. Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.Drugs & aging · 1996
    Review
11. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.Drugs & aging · 1995
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as